Synergist capable of enhancing toxicity of pesticide to bactrocera dorsalis
By downregulating the expression of the genes CPAP3-5, CPLCG-4, or RR1-52 in the oriental fruit fly using RNA interference, the toxicity of insecticides to the oriental fruit fly was enhanced, solving the problems of insecticide resistance and environmental pollution, and achieving the goal of green agriculture.
Patent Information
- Application Number
- CN202511850611.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-10
- Publication Date
- 2026-01-09
- Estimated Expiration
- 2045-12-10
AI Technical Summary
Current technologies lack synergists that can enhance the penetration efficiency of insecticides against the oriental fruit fly by specifically regulating the physiological barrier of the pest's body wall, leading to high levels of pesticide resistance in oriental fruit fly populations and environmental pollution problems.
By downregulating the expression levels of the genes CPAP3-5, CPLCG-4, or RR1-52 in the oriental fruit fly using RNA interference, and then using dsRNA or engineered strains that recombinantly express dsRNA, the toxicity of pesticides to the oriental fruit fly can be enhanced.
It significantly enhances the toxicity of insecticides to the oriental fruit fly, reduces the amount of chemical insecticides used, lowers pesticide residues and environmental pressure, and aligns with the development direction of green agriculture.
Smart Images

Figure CN121294551A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biological pesticide technology, specifically relating to a synergist that can enhance the toxicity of pesticides to the oriental fruit fly. Background Technology
[0002] The orchid fruit fly ( Bactrocera dorsalis The oriental fruit fly (Bactrocera dorsalis) belongs to the family Bactroceridae in the order Diptera. It is a globally recognized quarantine pest that bores into fruits and vegetables, causing severe damage. It has a wide host range, infesting more than 250 kinds of economically important fruits and vegetables. Native to subtropical regions, it is a significant pest of the fruit and vegetable industry in southern my country. In recent years, due to global climate change and the insect's increased adaptability, its distribution range has expanded northward, even invading previously unsuitable climatic areas, posing a major threat to the safety of my country's fruit and vegetable industry.
[0003] Except for the adult stage, the oriental fruit fly lives in secrecy throughout its various life stages. Therefore, current cost-effective control strategies primarily focus on chemical control of the adult stage. However, the long-term, singular, and excessive use of insecticides has directly led to the development of high-level pesticide resistance in oriental fruit fly populations in the field, while also causing serious environmental pollution and pesticide residue exceeding standards. Therefore, developing pesticide synergists that can effectively reverse or delay resistance and enhance the efficacy of existing pesticides has become an urgent need in the field of pest resistance management.
[0004] Currently, there is a lack of synergists on the market that can enhance the penetration efficiency of insecticides against the oriental fruit fly by specifically regulating the physiological barrier of the insect's body wall. Therefore, in-depth research into the mechanism of synergistic insecticide toxicity can provide new ideas and theoretical basis for the development of a new generation of green and efficient pest control products, which has important scientific significance and application prospects. Summary of the Invention
[0005] The purpose of this invention is to provide a synergist that enhances the toxicity of pesticides to the oriental fruit fly, and this synergist can downregulate the oriental fruit fly gene. CPAP3-5 , CPLCG-4 or RR1-52 The expression level of [something] can be increased, thereby enhancing the toxicity of insecticides to the oriental fruit fly.
[0006] This invention first provides a method for increasing the toxicity of pesticides to the oriental fruit fly. The method involves reducing the toxicity of pesticides to the oriental fruit fly. CPAP3-5 , CPLCG-4 or RR1-52 Gene expression levels; The aforementioned CPAP3-5 , CPLCG-4 or RR1-52 The genes, whose nucleotide sequences are SEQ ID NO:1-3; The method described uses RNA interference to reduce CPAP3-5 ,CPLCG-4 or RR1-52 expression of the gene in B. dorsalis; Further, the RNA interference method, wherein the dsRNA for reducing CPAP3-5 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 4; the dsRNA for reducing CPLCG-4 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 5; the dsRNA for reducing RR1-52 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 6.
[0007] The pesticide, as a specific embodiment, is chlorpyrifos, lambda-cyhalothrin, spinosad or emamectin benzoate.
[0008] The present application also provides a synergist for enhancing the toxicity of a pesticide to B. dorsalis, comprising an agent for reducing the expression of the gene CPAP3-5 、 CPLCG-4 or RR1-52 in B. dorsalis; The agent, as a specific embodiment, is a dsRNA or an engineered strain for recombinantly expressing the dsRNA; the dsRNA for reducing CPAP3-5 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 4; the dsRNA for reducing CPLCG-4 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 5; the dsRNA for reducing RR1-52 the expression of the gene is a dsRNA with the sequence of SEQ ID NO: 6.
[0009] The present application finds that down-regulating the expression of the genes Figure 1 、 Figure 2 and Figure 3 in B. dorsalis can significantly enhance the toxicity of insecticides to B. dorsalis through transcriptome and fluorescence quantification. Therefore, down-regulating the expression of key cuticular protein genes in the body wall of pests can promote the effect of insecticides, effectively reduce the use amount of chemical insecticides, reduce pesticide residues and environmental pressure, and meet the development direction of green agriculture. BRIEF DESCRIPTION OF DRAWINGS
[0010] Figure 4 : Figure of the effect of methyl eugenol exposure on the toxicity of chlorpyrifos, wherein ME and MO represent methyl eugenol and mineral oil respectively, and the error bar represents the 95% confidence interval of LD 50 .
[0011] Figure 5Figure 1: Effect of methyl eugenol exposure on toxicity of lambda-cyhalothrin, where ME and MO represent methyl eugenol and mineral oil, respectively, and error bars represent 95% confidence intervals of LD 50 .
[0012] Figure 6 Figure 2: Effect of methyl eugenol exposure on toxicity of emamectin benzoate, where ME and MO represent methyl eugenol and mineral oil, respectively, and error bars represent 95% confidence intervals of LD 50 .
[0013] Figure 7 Figure 3: Effect of methyl eugenol exposure on toxicity of spinosad, where ME and MO represent methyl eugenol and mineral oil, respectively, and error bars represent 95% confidence intervals of LD 50 .
[0014] Figure 8 Figure 4: Downregulation of CPAP3-5 expression levels after methyl eugenol exposure, where ME and MO represent methyl eugenol and mineral oil, respectively, and * represents a significant difference, P < 0.05.
[0015] Figure 9 Figure 5: Downregulation of CPLCG-4 expression levels after methyl eugenol exposure, where ME and MO represent methyl eugenol and mineral oil, respectively, and * represents a significant difference, P <0.05.
[0016] Figure 10 Figure 6: Downregulation of RR1-52 expression levels after methyl eugenol exposure, where ME and MO represent methyl eugenol and mineral oil, respectively, and * represents a significant difference, P <0.05.
[0017] Figure 11 Figure 7: Interference efficiency of CPAP3-5 gene, where * represents a significant difference, P <0.05.
[0018] Figure 12 Figure 8: Interference efficiency of CPLCG-4 gene, where * represents a significant difference, P <0.05.
[0019] Figure 13 Figure 9: Interference efficiency of RR1-52 gene, where * represents a significant difference, P <0.05.
[0020] Figure 1 Figure 10: Experimental results of effect of RNAi interference of CPAP3-5 on toxicity of four insecticides, where * represents a significant difference, P<0.05.
[0021] Figure 2 The figure shows the experimental results of the effect of RNAi interference with CPLCG-4 on the toxicity of four insecticides. * indicates a significant difference. P <0.05.
[0022] Figure 3 The figure shows the experimental results of the effect of RNAi interference with RR1-52 on the toxicity of four insecticides. * indicates a significant difference. P <0.05. Detailed Implementation
[0023] The CPAP3-5 gene involved in this embodiment of the invention has the following nucleotide sequence: ATGAAATATTCGTTTCTGTATTTAACACTTGTCACTTTGACGGTGTGCATCGTAGCGGAAAGTGCATTCCAATGTCCCAAACCTGAGGGCGAATATCCTGATGATGTTCAGTGTGATAAATACTATCAATGTAATGATGGCGTAGCAAAAGAAAAGTTGTGCCCAGATGGCTTAGTGTTCGATCCGCTCAATAGGCACATCAATAAGTGTGATCAACCTTTCAATGTAGATTGCGGTGACCGAACTGAATTGCAGGAGCCAAAATCTTCTAAATTTTGTCCTCGTAAAAACGGATTCTTCGCACATCCTGATTCTTCTGTATGTGATATTTTTTACAATTGTATTGATGGAGATGCTTTAGAAATGAAATGTACTGTTGGATTGCACTTTGATGAATTTGGTGGAACTTGTGTTTGGCCAGATACTGCGAAACGTGAAGGTTGCGAAGCACCACAGAAAAAATCTCCGACCGGATTTGTGTGCCCGAAGGATCGCCCAAAGAATGATGATAAAGGTCAGGTAGTTACTCATCCGAAGTTCCCCCATCCTACAGACTGTCAAAAATTCCATGTCTGCTTAAATGGGGAAGATCCACGCGATCTAGCCTGTCAATTAGGCGAAGTCTACAATGAAGAAACGGAAATGTGTGATGCTCCTGAAAATGTTCCCGGTTGTGAAGATTGGTACAAGGATTCCGATGACAAAAAAGAATAA (SEQ ID NO:1).
[0024] The nucleotide sequence of the CPLCG-4 gene is as follows: ATGAAGTTCGCCGTCTCCGTAGTCTTGTTCGCTTTGGCCCTTGGCGCTGCCCACTGCTCGGTCGTACCATTGATCAGTCAAATCAATGGCGCCGTTTTGGCCTCACCACTTGGTTCCGTTGCCGTACATGCCGCCGCCGTGCCAGCCGTTGTCGCCGCCCCAGCACCAGTACAGATCATCACCGCTCCCGCCGTGGTAGCTGCTCCCGCTGTCGTGGCCGCTGAAGGCACCTATGTGGCTAAGACCCGTGGCGCTGTACATGTGGCACCACTGCCCGGTCACATACAATCGGCAGCATCAGTGAACTTGCAACCAGCTCCTGGCACTCTCTAA (SEQ ID NO:2).
[0025] The nucleotide sequence of the RR1-52 gene is as follows: (SEQ ID NO:3).
[0026] The present invention will now be described in detail with reference to the embodiments and accompanying drawings.
[0027] Example 1: Effect of methyleugenol on the expression of epidermal protein genes in the body wall of the oriental fruit fly. 1. Methyleugenol exposure treatment of adult oriental fruit flies Given that individuals at different developmental stages may be exposed to methyl eugenol (ME) during field control, four experimental groups were set up: sexually immature males and females (3 days old), and sexually mature males and females (15 days old) that had not yet mated, all exposed to methyl eugenol (800 µL). The methyl eugenol release device was prepared as follows: methyl eugenol was evenly added dropwise to a petri dish (10 cm in diameter) lined with filter paper, and the surface was covered with 50-mesh gauze and secured with rubber bands to prevent the oriental fruit fly from directly ingesting the methyl eugenol. This release device and adult oriental fruit flies were placed together in a 1.5 mL centrifuge tube containing 20% sucrose solution and a 1 L plastic cup, the cup openings sealed with sealing film. The control group used an equal volume of mineral oil instead of methyl eugenol. Each treatment group contained at least 200 insects, with 50 adults placed in each cup.
[0028] Based on information registered on the China Pesticide Information Network, four commonly used insecticides for controlling the oriental fruit fly—chlorpyrifos, cypermethrin, abamectin, and spinosad—were selected to evaluate the effect of methyl eugenol exposure on their toxicity. The specific procedures were as follows: After 24 hours of methyl eugenol treatment, the test insects were briefly stunned at 4 °C, then transferred to an ice tray. The insecticide was applied by dripping onto the pronotum of the adult insects using a Hamilton PB-600 repeat dispenser. After treatment, the adults were transferred to disposable paper cups, the cup openings were sealed with clean gauze, and a cotton ball soaked in a 20% sucrose solution was placed on the gauze. The control group was treated with acetone. Mortality was observed and recorded after 24 hours; death was defined as no reaction when the insect was lightly touched with a brush. Five to seven concentration gradients were established for each insecticide, with three replicates per concentration and 10-15 adults per replicate.
[0029] Bioassay results showed that methyl eugenol exposure generally enhanced the toxicity of different insecticides to adult oriental fruit flies, but differences existed between different insecticides and different physiological states of adults. For example, for chlorpyrifos, methyl eugenol exposure significantly reduced the LD50 in adults at all four physiological states. 50 ( Figure 4 For high-efficiency cypermethrin, except for sexually mature female insects, the other three groups of insects all showed a significant reduction in LD50. 50 ( Figure 5 For abamectin, only immature and sexually mature males showed significantly increased sensitivity, while there was no significant difference between the two groups of females. Figure 6 For spinosad, only the toxicity against sexually mature males was significantly increased; there were no significant differences in the other three groups. Figure 7 Among them, after exposure to methyl eugenol, the decrease in sexually immature males was smallest after treatment with abamectin (1.68 times), while the decrease in sexually mature males was largest after treatment with chlorpyrifos (3.61 times). These results indicate that methyl eugenol not only has strong attractant activity for sexually mature males, but also significantly enhances the toxic effect of insecticides on them.
[0030] 2. Total RNA extraction and cDNA synthesis Fruit fly samples treated with methyl eugenol and mineral oil (control) for 24 hours were collected for total RNA extraction and cDNA synthesis. The specific procedures were as follows: Total RNA was extracted according to the Invitrogen TRIzol® Reagent instructions. After homogenization, chloroform was added and centrifuged at 4°C. The supernatant was collected, and isopropanol was added, followed by centrifugation at 4°C to precipitate RNA. The precipitate was washed twice with 75% ethanol, dried at room temperature, dissolved in 100 μL DEPC-H2O, and stored at -80°C after concentration determination. cDNA synthesis was performed using TaKaRa PrimeScript. ® Use the RT reagent kit with gDNA Eraser according to the instructions.
[0031] 3. Quantitative Real-Time PCR Analysis Transcriptome data showed that the expression of three epidermal protein genes in *Bactrocera dorsalis* differed significantly 24 hours after exposure to methyl eugenol. To verify its potential role in enhancing the contact toxicity of insecticides with methyl eugenol, we used quantitative real-time PCR to detect the expression of these genes. Primer selection was performed as follows: cDNA templates were serially diluted 2-fold, and six concentration gradients were set for quantitative real-time PCR screening. Primers with amplification efficiency between 90% and 110% and a single-peak melting curve were selected as the primers for the formal experiments.
[0032] cDNA from different treatment groups of *Bactrocera dorsalis* was used as qPCR template. Two replicates were performed for each target gene. The reaction system was prepared according to the ChamQ Universal SYBR qPCR Master Mix (Novitamin) instructions. The primer sequences used are as follows: CPAP3-5: F: 5'-TCCAATGTCCCAAACCTGAGG-3, R: 5'-AGCCATCTGGGCACAACTTTT-3'; CPLCG-4: F: 5'-ATGAAGTTCGCCGTCTCCGT-3', R: 5'-TACGGCAACGGAACCAAGTG-3'; RR1-52: F: 5'-CCTTAGTTGCCATTGCCGC-3', R: 5'-ATCGGCATCGGGTCTCCTCC-3'.
[0033] Transcriptome analysis showed that, in sexually mature males, compared with the mineral oil control group, methyl eugenol exposure significantly downregulated the expression of epidermal protein genes CPAP3-5, CPLCG-4, and RR1-52. To further investigate the mechanism of action of methyl eugenol in adult *Bacteroides citrinum* at different physiological stages, we analyzed the expression levels of three genes in the body wall tissues of four groups: sexually immature females, sexually immature males, sexually mature females, and sexually mature males. The results showed that CPAP3-5 was significantly downregulated in all four groups, with expression levels decreasing by 3.68, 3.72, 2.29, and 5.00-fold in sexually immature males, sexually immature females, sexually mature females, and sexually mature males, respectively. Figure 8 CPLCG-4 expression was significantly downregulated in both sexually immature females and sexually mature males, decreasing by 2.57 and 2.20-fold, respectively, while no significant difference was observed in the other two groups. Figure 9 ); RR1-52 expression was significantly decreased in all three groups except for sexually mature females, decreasing by 2.06, 1.32, and 8.23 times in sexually immature females, sexually immature males, and sexually mature males, respectively. Figure 10 ).
[0034] Example 2: Determining the effect of epidermal protein gene RNA interference on insecticide toxicity 1. Synthesis of double-stranded RNA Specific primers containing the T7 RNA polymerase promoter sequence were designed using the E-RNAi website tool. Double-stranded RNA (dsRNA) was synthesized according to the T7 High Yield Transcription Kit (Thermo Fisher Scientific) instructions, with enhanced green fluorescent protein (EGFP) dsRNA used as a control. The synthesized dsRNA was dissolved in nuclease-free water and quantified and quality-controlled by agarose gel electrophoresis and NanoDrop 2000 for subsequent RNA interference experiments.
[0035] The dsRNA targeting the CPAP3-5 gene is named dsCPAP3-5, and its nucleotide sequence is as follows: GATCCGCTCAATAGGCACATCAATAAGTGTGATCAACCTTTCAATGTAGATTGCGGTGACCGAACTGAATTGCAGGAGCCAAAATCTTCTAAATTTTGTCCTCGTAAAAACGGATTCTTCGCACATCCTGATTCTTCTGTATGTGATATTTTTTACAATTGTATTGATGGAGATGCTTTAGAAATGAAATGTACTGTTGGATTGCACTTTGATGAATTTGGTGGAACTTGTGTTTGGCCAGATACTGCGAAACGTGAAGGTTGCGAAGCACCACAGAAAAAATCTCCGACCGGATTTGTGTGCCCGAAGGATCGCCCAAAGAATGATGATAAAGGTCAGGTAGTTACTCATCCGAAGTTCCCCCATCCTACAGACTGTCAAAAATTCCATGTCTGCTTAAATGGGGAAGATCCACGCGATCTAGCCTGTCAATTAGGCGAAGTCTACAATGAAGAAACGGAAATGTGTGATGCTCCTGAAAATGTTCCCGGTTGTGAAG (SEQ ID NO:4).
[0036] The dsRNA targeting the CPLCG-4 gene, named dsCPLCG-4, has the following nucleotide sequence: CGTCTCCGTAGTCTTGTTCGCTTTGGCCCTTGGCGCTGCCCACTGCTCGGTCGTACCATTGATCAGTCAAATCAATGGCGCCGTTTTGGCCTCACCACTTGGTTCCGTTGCCGTACATGCCGCCGCCGTGCCAGCCGTTGTCGCCGCCCCAGCACCAGTACAGATCATCACCGCTCCCGCCGTGGTAGCTGCTCCCGCTGTCGTGGCCGCTGAAGGCACCTATGTGGCTAAGACCCGTGGCGCTGTACATGTGGCACCACTGCCCGGTCACATACAATCGGCAGCATCAGTGAACTTGCAACCAGCTC (SEQ ID NO:5).
[0037] The designed dsRNA targeting RR1-52, named dsRR1-52, has the following nucleotide sequence: GTAGATCCTACAGGCGAGCGTCGTACAATTTCCTACACTGCTGGCAAAAATGGTTTCCAAGCTAGCGGTGATCACTTGCCCGTACCACCACCAGCTCCACCACAACCCGTGCCACAACCGGGCTACGCACCACAGCCACAATACCAGCCACCAGCACAGTCGGGCGGTTACCGCAGCAACGACTACGATGACGGTTCGTACGATCCACGTTACAATGATCCCGGTTTCGG TCAGCAACAAGGTGGTTATCAGGCACCACAACCGCAATATCAGCCACCAGCACCCGCCTACAATCCACCACCACAACAGCCAGCATATAATCCACCGGCGCCACAATACAACAGCTACCAAGCACAACAACAACCCTACTATCACAGACCACACCCAATCCACACCGCTTCGCACCACCCGGCAAATTGTCGCTGAATCGCACACCAGACGGCTTTAGCT (SEQ ID NO:6).
[0038] 2. Microinjection of dsRNA into the oriental fruit fly Using a Nanoliter 2000 microinjection system, 4 μg of dsRNA from the three genes mentioned above was injected into the abdominal segment between the first and second abdominal segments of adult insects. Twenty-four hours after injection, test insects were randomly collected, and gene silencing efficiency was detected by quantitative real-time PCR, along with their sensitivity to insecticides.
[0039] Insecticide susceptibility testing was performed using the drop method, with the application dose being the LD50 of each insecticide. 50 Concentration. Each treatment was repeated 5 times, with 10 adults per replicate.
[0040] 3. RNAi results 24 h after dsRNA injection, RT-qPCR results showed that the transcriptional levels of CPAP3-5, CPLCG-4, and RR1-52 decreased by 82.15% ( Figure 11 ), 83.30% Figure 12 ) and 67.67% Figure 13 This indicates that the gene silencing effect is significant.
[0041] After effective gene silencing, the test insects exhibited varying degrees of sensitivity changes to chlorpyrifos, lambda-cyhalothrin, spinosad, and abamectin. Compared to the dsEGFP control group, CPAP3-5 silencing significantly increased the toxicity to chlorpyrifos and lambda-cyhalothrin by 29.96% and 33.82%, respectively, while there were no significant differences in the toxicity to the other two insecticides. After silencing CPLCG-4, the toxicity to chlorpyrifos, abamectin, and spinosad was significantly increased by 29.23%, 13.94%, and 33.94%, respectively, while the toxicity to lambda-cypermethrin was not significantly affected. After RR1-52 silencing, the toxicity to chlorpyrifos and abamectin was significantly increased by 12.71% and 33.81%, respectively, but had no significant effect on the toxicity to spinosad. ).
[0042] The results show that silencing the CPAP3-5, CPLCG-4, and RR1-52 genes can enhance the sensitivity of pests to insecticides. These three genes play specific regulatory roles with partially overlapping functions in the detoxification or resistance processes of different types of insecticides.
Claims
1. A method for enhancing the toxicity of pesticides against the oriental fruit fly, characterized in that, The method described is to reduce the expression levels of the CPAP3-5 gene, CPLCG-4 gene, or RR1-52 gene in the oriental fruit fly.
2. The method as described in claim 1, characterized in that, The CPAP3-5 gene has a nucleotide sequence of SEQ ID NO:1, the CPLCG-4 gene has a nucleotide sequence of SEQ ID NO:2, and the PAP3-5 gene has a nucleotide sequence of SEQ ID NO:
3.
3. The method as described in claim 1, characterized in that, The method described uses RNA interference to reduce the expression levels of the CPAP3-5, CPLCG-4, or RR1-52 genes in the oriental fruit fly.
4. The method as described in claim 3, characterized in that, The RNA interference method described herein includes a dsRNA for reducing the CPAP3-5 gene, the sequence of which is SEQ ID NO:
4.
5. The method as described in claim 3, characterized in that, The RNA interference method described herein, wherein the dsRNA used to reduce the CPLCG-4 gene has the sequence SEQ ID NO:
5.
6. The method as described in claim 3, characterized in that, The RNA interference method described herein includes a dsRNA for reducing the RR1-52 gene, the sequence of which is SEQ ID NO:
6.
7. The method as described in claim 1, characterized in that, The pesticides mentioned are chlorpyrifos, cypermethrin, spinosad, or abamectin.
8. A synergist that enhances the toxicity of pesticides against the oriental fruit fly, characterized in that, The synergist contains reagents for reducing the expression levels of the CPAP3-5, CPLCG-4, or RR1-52 genes in the oriental fruit fly.
9. The synergist as described in claim 8, characterized in that, The reagent is dsRNA or an engineered strain used for recombinant expression of dsRNA.
10. The synergist as described in claim 9, characterized in that, The dsRNAs described herein include the dsRNA for reducing the CPAP3-5 gene, the sequence of which is SEQ ID NO:4; the dsRNA for reducing the CPLCG-4 gene, the sequence of which is SEQ ID NO:5; and the dsRNA for reducing the RR1-52 gene, the sequence of which is SEQ ID NO:6.
Citation Information
Patent Citations
Method for gene regulation and control of bactrocera dorsalis breeding
CN116218917A
DsRNA and pesticide compound for preventing and treating bactrocera dorsalis
CN118497206A
Application of BdCA1 gene in prevention and treatment of bactrocera dorsalis
CN118755709A
Application of epidermal protein gene SlituCP26 in prevention and treatment of prodenia litura
CN119410649A
Inhibitor for suppressing expression of antibacterial peptide in brown planthopper and application thereof
JP2025142446A
